← Back
$GENB All transactions

Generate Biomedicines, Inc.

C

$ Value

$0

Shares

1,100,000

Price

$0

Filed

Mar 2

Insider

Name

Bancel Stephane

Title

CIK

0001443340

Roles

Director

Transaction Details

Transaction Date

2026-03-02

Code

C

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

Each share of Series A Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-1.5190 basis upon the closing of the Issuer's initial public offering on March 2, 2026. The Series A Preferred Stock had no expiration date. | Shares held by OCHA LLC, of which the Reporting Person is the controlling unit holder and sole managing member. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. | The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date.

Filing Info

Accession No.

0001193125-26-085881

Form Type

4

Issuer CIK

0002100782

Bancel Stephane's History

Date Ticker Type Value
2026-03-02 GENB C
2026-03-02 GENB C $0
2026-03-01 MRNA A $0
2026-02-26 GENB A $0
2026-02-11 MRNA A $0
2026-02-11 MRNA F $229K
2025-12-11 MRNA M $7.5M
2025-12-11 MRNA M $0

Other Insiders at GENB (90d)

Insider Bought Sold Last
AFEYAN NOUBAR $150.0M 2026-03-02
Nally Michael
Chief Executive Officer
$240K 2026-03-04
Silvers Jason
President & CFO
$32K 2026-03-02
Mendillo Jane L $24K 2026-03-02
Grous Beth
Chief People Officer
$5K 2026-03-02
Fanucci Marsha 2026-02-26
Simonian Nancy A 2026-02-26
Bancel Stephane 2026-03-02
Martin Sean
Chief Legal Officer & GC
2026-02-26
ARNOLD FRANCES 2026-02-26
Vessey Rupert 2026-02-26
Parker Paul Gray 2026-02-26
Grigoryan Gevorg
Chief Technology Officer
2026-02-26
Lee Laurie Anne
Chief Medical Officer
2026-02-26